Universe Pharmaceuticals Inc. (UPC) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Universe Pharmaceuticals Inc. (UPC:NASDAQ), powered by AI.

Current Price
$2.89
Sector
Healthcare
What is the Universe Pharmaceuticals Inc. stock price forecast?

Universe Pharmaceuticals Inc. is currently trading at $2.89. View real-time AI analysis on Alpha Lenz.

What is Universe Pharmaceuticals Inc. insider trading activity?

View the latest insider trading data for Universe Pharmaceuticals Inc. on Alpha Lenz.

What is Universe Pharmaceuticals Inc.'s P/E ratio?

View Universe Pharmaceuticals Inc.'s valuation metrics on Alpha Lenz.

Universe Pharmaceuticals Inc.

NASDAQ · UPC
$2.89-0.23(-7.37%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Universe Pharmaceuticals Inc.'s future dividend policy...
Alpha Chat Insight

Universe Pharmaceuticals Inc.'s ROE is -7.2%. Explore profitability and growth together.

Ask for details

Company Overview

Universe Pharmaceuticals Inc. is a specialized company in the pharmaceutical industry focused on traditional Chinese medicine. The company's primary function is the manufacturing, marketing, and distribution of pharmaceuticals, with a significant portion of its products based on traditional Chinese herbal medicines. Universe Pharmaceuticals leverages ancient Chinese medical practices, integrating them with modern processing technologies to create a range of health and wellness products addressing various consumer needs. Notable features of Universe Pharmaceuticals include its extensive portfolio of over-the-counter medicine, dietary supplements, and skincare products that appeal to both domestic and international markets. With operations rooted in applying and preserving traditional knowledge, the company impacts sectors including healthcare, wellness, and consumer goods. In the context of financial markets, Universe Pharmaceuticals Inc. represents a blend of cultural heritage with contemporary scientific approaches, positioning itself uniquely as a bridge between traditional remedies and modern pharmaceuticals. Its presence in the market reflects growing consumer interest in alternative and holistic healthcare solutions, contributing to the diversification of the pharmaceutical industry.

CEOMr. Gang Lai
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees225

Company Statistics

FY 2025

Profile

N/AMarket Cap
$17.86MRevenue
0.00Shares Out
225Employees

Margins

35.28%Gross
-13.67%EBITDA
-16.33%Operating
-20.56%Pre-Tax
-20.56%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

-23.66%Rev 3Yr
-10.27%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-5.35%ROA
-7.23%ROE
-5.01%ROIC

Financial Health

$33.59MCash & Cash Equivalents
$-20.42MNet Debt
23.47%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Universe Pharmaceuticals Inc. (ticker: UPC) is a company listed on NASDAQ in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 225 employees.

The current price is $2.89 with a P/E ratio of -x and P/B of -x.

ROE is -7.23% and operating margin is -16.33%. Annual revenue is $18M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Universe Pharmaceuticals Inc. (UPC) Stock Forecast 2026 $2.89 — Price, Financials & Analyst Targets | Alpha Lenz